Katherine J. Motyl

ORCID: 0000-0002-8301-8737
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bone health and osteoporosis research
  • Adipose Tissue and Metabolism
  • Bone Metabolism and Diseases
  • Bone health and treatments
  • CRISPR and Genetic Engineering
  • bioluminescence and chemiluminescence research
  • Vitamin D Research Studies
  • MicroRNA in disease regulation
  • Diet and metabolism studies
  • Stress Responses and Cortisol
  • Adipokines, Inflammation, and Metabolic Diseases
  • Parathyroid Disorders and Treatments
  • Genetics, Aging, and Longevity in Model Organisms
  • Growth Hormone and Insulin-like Growth Factors
  • Metabolism, Diabetes, and Cancer
  • Exercise and Physiological Responses
  • Pain Mechanisms and Treatments
  • Bone and Joint Diseases
  • Schizophrenia research and treatment
  • Receptor Mechanisms and Signaling
  • Regulation of Appetite and Obesity
  • Thermoregulation and physiological responses
  • Pluripotent Stem Cells Research
  • Molecular Biology Techniques and Applications
  • Dietary Effects on Health

MaineHealth
2020-2024

University of Maine
2020-2024

Tufts University
2020-2024

Maine Medical Center Research Institute
2011-2022

Maine Medical Center
2011-2022

Research Network (United States)
2020-2022

Michigan State University
2006-2015

Laboratoire d’Imagerie Biomédicale
2011

Type 1 diabetes (T1D)–induced osteoporosis is characterized by a predominant suppression of osteoblast number and activity, as well increased bone marrow adiposity but no change in osteoclast activity. The fundamental mechanisms alternative anabolic treatments (with few side effects) for T1D loss remain undetermined. Recent studies our laboratory others indicate that probiotics can benefit health. Here, we demonstrate Lactobacillus reuteri, probiotic with anti-inflammatory health properties,...

10.1210/en.2015-1308 article EN Endocrinology 2015-07-02

As many as 50% of adults with type I (T1) diabetes exhibit bone loss and are at increased risk for fractures. Therapeutic development to prevent and/or restore lost in T1 diabetic patients requires knowledge the molecular mechanisms accounting pathology. Because cell culture models alone cannot fully address systemic/metabolic complexity diabetes, animal critical. A variety exist including spontaneous pharmacologically induced rodents. In this paper, we discuss streptozotocin (STZ)-induced...

10.1007/s12575-009-9000-5 article EN cc-by Biological Procedures Online 2009-03-06
Channabasavaiah B. Gurumurthy Aidan R. O’Brien Rolen M. Quadros John H. Adams Pilar Alcaide and 95 more Shinya Ayabe Johnathan Ballard Surinder K. Batra Marie-Claude Beauchamp Kathleen A. Becker Guillaume Bernas David Brough Francisco Carrillo‐Salinas Wesley Chan Hanying Chen Ruby Dawson Victoria DeMambro Jinke D’Hont Katharine M. Dibb James D. Eudy Lin Gan Jing Gao Amy Gonzales Anyonya R. Guntur Huiping Guo Donald W. Harms Anne Harrington Kathryn E. Hentges Neil Humphreys Shiho Imai Hideshi Ishii Mizuho Iwama Eric Jonasch Michelle Karolak Bernard Keavney Nay-Chi Khin Masamitsu Konno Yuko Kotani Yayoi Kunihiro Imayavaramban Lakshmanan Catherine Larochelle Catherine B. Lawrence Lin Li Volkhard Lindner Xian-De Liu Gloria López‐Castejón Andrew Loudon Jenna Lowe Loydie A. Jerome‐Majewska Taiji Matsusaka Hiromi Miura Yoshiki Miyasaka Benjamin Morpurgo Katherine J. Motyl Yo-ichi Nabeshima Koji Nakade Toshiaki Nakashiba Ken‐ichi Nakashima Yuichi Obata Sanae Ogiwara Mariette Ouellet Leif Oxburgh Sandra Piltz Ilka Pinz Moorthy P. Ponnusamy David Ray Ronald Redder Clifford J. Rosen Nikki Ross Mark Ruhe Larisa Ryzhova Ane Salvador Sabrina Alam Radislav Sedláček Karan Sharma Chad Smith Katrien Staes Lora Starrs Fumihiro Sugiyama Satoru Takahashi Tomohiro Tanaka Andrew W. Trafford Yoshihiro Uno Leen Vanhoutte Frederique Vanrockeghem Brandon Willis Christian S. Wright Yuko Yamauchi Xin Yi Kazuto Yoshimi Xuesong Zhang Yingxin Zhang Masato Ohtsuka Satyabrata Das Daniel J. Garry Tino Hochepied Paul Thomas Jan Parker‐Thornburg Antony Adamson Atsushi Yoshiki

CRISPR-Cas9 gene-editing technology has facilitated the generation of knockout mice, providing an alternative to cumbersome and time-consuming traditional embryonic stem cell-based methods. An earlier study reported up 16% efficiency in generating conditional (cKO or floxed) alleles by microinjection 2 single guide RNAs (sgRNA) single-stranded oligonucleotides as donors (referred herein "two-donor floxing" method).We re-evaluate two-donor method from a consortium 20 laboratories across...

10.1186/s13059-019-1776-2 article EN cc-by Genome biology 2019-08-25

Abstract Type 1 diabetic osteoporosis results from impaired osteoblast activity and death. Therefore, anti‐resorptive treatments may not effectively treat bone loss in this patient population. Intermittent parathyroid hormone (PTH) treatment stimulates remodeling increases density healthy subjects. However, PTH effects be limited patients with diseases that interfere its signaling. Here, we examined the ability of 8 40 µg/kg intermittent to counteract loss. reduced fat pad mass blood glucose...

10.1002/jcp.22844 article EN Journal of Cellular Physiology 2011-05-20

Abstract Type 2 diabetes (T2D) incidence in adolescents is rising and may interfere with peak bone mass acquisition. We tested the effects of early-onset T2D on mass, microarchitecture, strength TALLYHO/JngJ mouse, which develops by 8 weeks age. assessed metabolism skeletal acquisition male SWR/J controls (n = 8–10/group) from 4 to 17 Tallyho mice were obese; had an approximately 2-fold higher leptin percentage body fat; lower mineral density vs SWR at all time points (P < .03 for...

10.1210/en.2014-1041 article EN Endocrinology 2014-07-22

The difficulty in obtaining as well maintaining weight loss, together with the impairment of metabolic control conditions like diabetes and cardiovascular disease, may represent pathological situations inadequate neural communication between brain peripheral organs tissues. Innervation adipose tissues by nerves provides a means master regulator (chiefly hypothalamus), energy-expending energy-storing cells body (primarily adipocytes). Although chemical surgical denervation studies have...

10.1371/journal.pone.0221766 article EN cc-by PLoS ONE 2019-09-11

ABSTRACT Fat mass may be modulated by the number of brown-like adipocytes in white adipose tissue (WAT) humans and rodents. Bone remodeling is dependent on systemic energy metabolism and, with age, bone becomes uncoupled brown (BAT) function declines. To test interaction between BAT bone, we employed Misty (m/m) mice, which were reported deficient BAT. We found that mice have accelerated age-related trabecular loss impaired fat (including reduced temperature, lower expression Pgc1a, less...

10.1002/jbmr.1943 article EN Journal of Bone and Mineral Research 2013-04-02

Abstract Type I diabetes is associated with bone loss and marrow adiposity. To identify early events involved in the etiology of diabetic loss, was induced mice by multiple low dose streptozotocin injections. Serum markers metabolism inflammation as well tibial gene expression were examined between 1 17 days post‐injection (dpi). At 3 dpi, when blood glucose levels significantly elevated, body, fat pad muscle mass decreased. resorption formation decreased at 5 dpi remained suppressed...

10.1002/jcp.21626 article EN Journal of Cellular Physiology 2008-11-12

Abstract Leptin is a hormone secreted by adipocytes that implicated in the regulation of bone density. Serum leptin levels are decreased rodent models type 1 (T1‐) diabetes and diabetic patients. Whether mediates changes unclear. Therefore, we treated control T1‐diabetic mice with chronic (28 days) subcutaneous infusion or saline to elucidate therapeutic potential for osteoporosis. prevented increase marrow increased aP2 expression observed vehicle‐treated mice. However, did not prevent...

10.1002/jcp.21608 article EN Journal of Cellular Physiology 2008-10-17

Atypical antipsychotic (AA) drugs cause significant metabolic side effects, and clinical data are emerging that demonstrate increased fracture risk bone loss after treatment with the AA, risperidone (RIS). The pharmacology underlying adverse effects on is unknown. However, RIS action in central nervous system could be responsible because sympathetic (SNS) known to uncouple remodeling. mice significantly lowered trabecular volume fraction (bone volume/total volume), owing osteoclast-mediated...

10.1210/en.2015-1099 article EN Endocrinology 2015-04-08

Type I diabetes is characterized by little or no insulin production and hyperglycemic conditions. It also associated with significant bone loss increased marrow adiposity. To examine the role of reduced signaling in type diabetic without inducing hyperglycemia, we used genetically reconstituted receptor knockout mice (IRKO-L1) that are euglycemic as a result human transgene expression pancreas, liver, brain. RT-PCR analyses demonstrated undetectable levels IRKO-L1 bone, yet bones exhibit...

10.1210/en.2006-0700 article EN Endocrinology 2006-09-15

The increasing use of antipsychotics (APs) to treat pediatric psychiatric conditions has led concerns over the long-term tolerability these drugs. While risk cardiometabolic abnormalities received most attention, preclinical and clinical studies provide preliminary evidence that APs can adversely impact bone metabolism. This would be concerning in children adolescents as suboptimal accrual during development may lead increased fracture later life. However, potential mechanisms action through...

10.1177/2045125313487548 article EN Therapeutic Advances in Psychopharmacology 2013-04-30

Bone loss in type 1 diabetes is accompanied by increased marrow fat, which could directly reduce osteoblast activity or result from altered bone mesenchymal cell lineage selection (adipocyte vs. osteoblast). CCAAT/enhancer binding protein beta (C/EBPβ) an important regulator of both adipocyte and differentiation. C/EBPβ-null mice have delayed formation defective lipid accumulation brown adipose tissue. To examine the balance C/EBPβ functions diabetic context, we induced (knockout, KO) mice....

10.1152/ajpregu.00764.2010 article EN AJP Regulatory Integrative and Comparative Physiology 2011-02-24

There is a growing and alarming prevalence of obesity the metabolic syndrome in type I diabetic patients (T1DM), particularly adolescence. In general, low bone mass, higher fracture risk, increased marrow adipose tissue (MAT) are features osteopathy insulin‐deficient subjects. On other hand, 2 diabetes (T2DM) associated with normal or high greater risk peripheral fractures, no change MAT. Therefore, we sought to determine effect weight gain on turnover mice. We evaluated impact 6‐week...

10.1002/jcp.26062 article EN Journal of Cellular Physiology 2017-06-20

Trpm8 (transient receptor potential cation channel, subfamily M, member 8) is expressed by sensory neurons and involved in the detection of environmental cold temperatures. TRPM8 activity triggers an increase uncoupling protein 1 ( Ucp1 )-dependent brown adipose tissue (BAT) thermogenesis. Bone density marrow are both influenced rodent housing temperature tissue, but it unknown if co-regulation thermogenesis bone homeostasis. To address this, we examined phenotypes one-year-old knockout mice...

10.1371/journal.pone.0231060 article EN cc-by PLoS ONE 2021-06-04
Coming Soon ...